Portal de investigación
ESTUDIO DE FASE II, MULTICÉNTRICO Y ABIERTO PARA EVALUAR LA EFICACIA Y LA SEGURIDAD DE LA COMBINACIÓN CON DOSIS FIJA DE SOFOSBUVIR/VELPATASVIR EN SUJETOS CON INFECCIÓN CRÓNICA POR EL VHC QUE HAN RECIBIDO UN TRASPLANTE DE HÍGADO.
Datos básicos
- Código:
- GS-US-342-2104
- Protocolo:
- GS-US-342-2104
- EUDRACT:
- 2016-000416-15
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Dotación:
- Año de incio:
- 2016
- Año de finalización:
Documentos
- No hay documentos
Participantes
-
Carmen Vinaixa Aunés
Investigador Principal
-
Martín Prieto Castillo
Investigador Principal
-
Vanessa Hontangas Pla
Data Manager / Study Coordinator
Grupos
-
Hepatología experimental y Trasplante hepático
Investigador Principal
Laia Tolosa Pardo
Financiadores - Promotores
Resultados del Ensayo Clínico
HOW SHOULD I MANAGE HBV IN THE WAITLISTED PATIENT?
MARINA BERENGUER HAYM, J. FUNG
Capítulo de un Libro. 2017
"Posttransplant calcineurin inhibitors levels and intra-patient variability are not associated with long term outcomes following liver transplantation".
Di Maira T; (...); Berenguer M
Article. 10.1097/TP.0000000000002987. 2020
[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence
Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda
Editorial Material. 10.1016/j.farma.2024.08.009. 2024
[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Andrés JLP, Solsona MDE
Article. 10.1016/j.farma.2023.10.004. 2024
[Translated article] New challenges in advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2024.05.001. 2024
[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.
Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.12.007. 2025
[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.
Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda
Article. 10.1016/j.farma.2024.09.006. 2024
2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11611. 2021
A Century of Progress on Wilson Disease and the Enduring Challenges of Genetics, Diagnosis, and Treatment.
Penning, Louis C.; (...); Weiskirchen, Ralf
Article. 10.3390/biomedicines11020420. 2023
A multicenter study to assess the incidence of hepatocellular carcinoma recurrence after liver transplantation in patients treated with direct-acting antivirals for chronic hepatitis C
Gorgen, A; (...); Sapisochin, G
Meeting Abstract. 2018
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain
Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro
Article. 10.33393/grhta.2022.2333. 2022
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.
Zozaya, Neboa; (...); Verde, Luis
Article. 10.1017/S0266462322000459. 2022
A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.
de Andrés-Nogales F; (...); Martínez-Olmos J
Article. 10.1007/s41669-020-00201-2. 2020
A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.
Casado, MA; (...); Grp MULTIDEX-EMD
Meeting Abstract. 10.1016/j.jval.2018.09.2545. 2018
A new definition and refocus of pharmaceutical care: the Barbate Document
Morillo-Verdugo R; (...); Poveda-Andrés JL
Article. 10.7399/fh.11389. 2020
A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area.
Carvalho-Gomes Â; (...); Berenguer M
Article. 10.1371/journal.pone.0228351. 2020
Access to liver transplant for women in Spain: a national registry analysis
Tejedor Bravo, Marta; (...); Berenguer, Marina
Meeting Abstract. 2023
Access to liver transplant for women in Spain: a national registry analysis
Tejedor, M.; (...); Berenguer, M.
Meeting Abstract. 2023
Adaptation and validation of an abbreviated version of the SIPAT integrated psychosocial risk scale in patients with liver cirrhosis candidates for liver transplantation (SIPAT-11).
Garcia Morales, Natalia; (...); Cubiella, Joaquin
Article. 10.1016/j.gastrohep.2024.502220. 2024
Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.
Andacoglu, Oya; (...); Selzner, Nazia
Article. 10.3389/ti.2023.11240. 2023
Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.
Ballesta-López O; (...); Poveda-Andrés JL
Article. 10.1177/1078155220915953. 2020
Adoptive transfer of ex-vivo expanded SARS-CoV-2-specific Cytotoxic Lymphocytes: a viable strategy for COVID-19 immunosuppressed patients?
Guerreiro M; (...); Piñana JL
Article. 10.1111/tid.13602. 2021
Albumin dialysis with MARS for the treatment of anabolic steroid-induced cholestasis
Diaz, FC; (...); Prieto, M
Article. 10.5604/16652681.1222114. 2016
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives.
Gitto S; (...); Berenguer M
Editorial Material. 10.1155/2019/8691502. 2019
Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting The MENTE Study
Rodríguez-Nóvoa S; (...); Castro Á
Article. 10.1097/MCG.0000000000000569. 2016
An objective definition for clinical suspicion of T-cell-mediated rejection after liver transplantation
Rodriguez-Peralvarez, M; (...); De la Mata, M
Article. 10.1111/ctr.13005. 2017
Analysing criteria for price and reimbursement of orphan drugs in Spain.
Badia, X; (...); Tort, M
Article. 10.7399/fh.11147. 2019
Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/10781552211038518. 2021
Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference.
Chadha, Ryan; (...); Rela, Mohamed
Article. 10.1097/TP.0000000000004803. 2023
Antimicrobial stewardship programme implementation in a medical ward
Ruiz, J; (...); Poveda, JL
Article. 2018
Antimicrobial stewardship programme in critical care medicine: A prospective interventional study
Ruiz, J; (...); Catellanos, A
Article. 10.1016/j.medin.2017.07.002. 2018
Are MELD and MELDNa Still Reliable Tools to Predict Mortality on the Liver Transplant Waiting List?
Tejedor, Marta, Selzner, Nazia, Berenguer, Marina
Article. 10.1097/TP.0000000000004163. 2022
Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).
Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ
Letter. 10.1111/jdv.19432. 2023
Assessment of persistent COVID-19 in liver transplant recipients compared to immunocompetent individuals
Fernandez, A.; (...); Salcedo, M. M.
Meeting Abstract. 2023
Association of Cardiac Abnormalities to the Frail Phenotype in Cirrhotic Patients on the Waitlist: From the Functional Assessment in Liver Transplantation Study
Puchades, L; (...); Lai, JC
Article. 10.1097/TP.0000000000002025. 2018
ATP7B AND OTHER GENES RESULTING IN WILSON DISEASE (WD) PHENOTYPE
Sanchez-Monteagudo, A; (...); Berenguer, M
Meeting Abstract. 2019
Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles
Stephens, C; (...); Lucena, MI
Article. 10.1097/FPC.0000000000000230. 2016
Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
Martí-Aguado D; (...); Martí-Bonmatí L
Article. 10.1148/radiol.2021211027. 2022
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.
Iglesias Gómez R; (...); Poveda Andrés JL
Article. 10.1136/ejhpharm-2021-002741. 2021
Baseline features of hepatitis C patients associated to prescription of pangenotypic antiviral treatments: results from the real-world Spanish Hepa-C registry
Turnes, Juan; (...); Perez Cachafeiro, Santiago
Meeting Abstract. 2020
Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Megias-Vericat, JE; (...); Bonanad, S
Meeting Abstract. 2018
Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2018.12.027. 2019
Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.
Fernandez Rivera C; (...); Hernandez D
Article. 10.1111/ctr.14550. 2022
BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population
Perez-Huertas, P; (...); Poveda-Andres, JL
Article. 10.1177/1043454216631952. 2017
Brain abscesses in early post-liver transplantation.
Mínguez Sabater A; (...); Prieto Castillo M
Case Reports. 10.1016/j.eimc.2021.02.002. 2021
Brain abscesses in early post-liver transplantation.
Minguez Sabater, Alejandro; (...); Prieto Castillo, Martin
Article. 10.1016/j.eimce.2021.09.007. 2021
Breakthrough invasive fungal disease in high-risk hematologic malignancies in children: a single-center experience
Garcia-Robles, AA; (...); Fernandez-Navarro, JM
Meeting Abstract. 2017
CA125: a new biomarker in patients with Fontan circulation (vol 76, pg 112, 2023)
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Correction. 10.1016/j.rec.2023.03.018. 2023
CA125: a new biomarker in patients with Fontan circulation.
Fuentes, Francisco Buendia; (...); Soriano, Joaquin Rueda
Article. 10.1016/j.rec.2022.05.029. 2022
Can endothelial biomarkers before liver transplantation together with classical cardiovasculat risk factors be useful to predict cardiovascular risk after liver transplantation
Herreras Lopez, Julia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2022
Can endothelial biomarkers before LT together with classical cardiovascular risk factors be useful to predict cardiovascular risk after LT?
Herreras, J.; (...); Aguilera, V.
Article. 2022
Carbohydrate antigen 125 and glutamic oxaloacetic transaminase as congestion markers in acute heart failure. Is there clinical association between them?
Carrillo, D; (...); Almenar, L
Meeting Abstract. 2018
Circulating MicroRNAs: Dynamic Markers of Liver Transplant Injury.
Mas VR, Bardhi E, Berenguer M
Article. 10.1097/TP.0000000000003816. 2021
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease.
Simao, Andre Lopes; (...); Castro, Rui E
Article. 10.1016/j.jhepr.2023.100697. 2023
Clinical and molecular characterization of Wilson's disease in the Valencian Region
Sanchez-Monteagudo, A; (...); Espinos, C
Meeting Abstract. 2018
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients
Megias-Vericat, JE; (...); Poveda, JL
Article. 10.1016/j.thromres.2021.07.009. 2021
Clinical characteristics and outcomes of elderly included in the Spanish Drug-Induced Liver Injury (DILI) Registry
Slim, M; (...); Andrade, RJ
Meeting Abstract. 10.1016/S0168-8278(17)31154-6. 2017
Clinical Outcomes in biopsy-proven NAFLD patients from the HEPAmet Spanish Registry
Ampuero, J; (...); Gomez, MR
Meeting Abstract. 10.1016/S0168-8278(18)31942-1. 2018
Clinical outcomes of patients delisted from thewaiting list of liver transplantation after interferon-free antiviral therapy
Pascasio, JM; (...); Londono, MC
Meeting Abstract. 10.1016/S0168-8278(17)30661-X. 2017
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantation
Pascasio, JM; (...); Londoño MC
Article. 10.1016/j.jhep.2017.08.008. 2017
Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model
Nogueras, A; (...); Calleja, MA
Letter. 10.1136/ejhpharm-2019-001905. 2019
CLINICAL PRESENTATION AND OUTCOMES OF DE NOVO HEPATITIS B VIRUS INFECTION AFTER LIVER TRANSPLANTATION IN SPAIN.
Pascasio Acevedo, Juan Manuel; (...); Manuel Sousa, Jose
Meeting Abstract. 2019
CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)
Aguilera, V.; (...); Berenguer, M.
Meeting Abstract. 2023
CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
CMV reactivation is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT)
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2022
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
Kowdley KV; (...); Villamil A
Article. 10.14309/ajg.0000000000003029. 2024
Collaborative model of home delivery program in haemophilia through an association of patients
Megias-Vericat, JE; (...); Bonanad, S
Meeting Abstract. 2018
Combined Resistance and Endurance Training at a Moderate-to-High Intensity Improves Physical Condition and Quality of Life in Liver Transplant Patients
Moya-Najera, D; (...); Colado, JC
Article. 10.1002/lt.24827. 2017
Community acquired respiratory virus infections in adult patients undergoing umbilical cord blood transplantation.
Montoro J; (...); Piñana JL
Article. 10.1038/s41409-020-0943-0. 2020
Comparative effects of second-line therapy with obeticholic acid or fibrates in primary biliary cholangitis patients
Reig, Anna; (...); Pares, Albert
Meeting Abstract. 2020
Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo
Megias-Vericat, JE; (...); Poveda, JL
Meeting Abstract. 2020
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI registry.
Stephens C; (...); Andrade RJ
Article. 10.1016/j.jhep.2021.01.029. 2021
Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020).
Rodríguez M; (...); García-Samaniego J
Article. 10.1016/j.gastrohep.2020.03.011. 2020
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline
Aller, R; (...); Romero-Gomez, M
Correction. 10.1016/j.gastrohep.2018.05.011. 2018
Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline
Aller, R; (...); Romero-Gomez, M
Review. 10.1016/j.gastrohep.2017.12.003. 2018
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano JB; (...); Soto-Ortega I
Article. 10.1016/j.farma.2023.01.003. 2023
Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.
Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada
Article. 10.1016/j.farma.2023.04.002. 2023
Controlling Diabetes After Liver Transplantation: Room for Improvement
Alvarez-Sotomayor D; (...); Berenguer M
Article. 10.1097/TP.0000000000001399. 2016
Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
Kowdley, Kris V; (...); Villamil, Alejandra
Article. 10.14309/ajg.0000000000003153. 2024
Corrigendum to "Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives".
Gitt S; (...); Berenguer M
Correction. 10.1155/2020/4305190. 2020
COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA
Gironella, M.; (...); Oyaguez, I
Meeting Abstract. 2019
COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN
Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.
Meeting Abstract. 2024
Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1080/13696998.2017.1311903. 2017
Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.
Poveda JL; (...); Torres C
Article. 10.1080/14737167.2019.1635014. 2020
COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN
Trillo, JL; (...); Torres, C
Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018
COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN
Bonanad, S; (...); Gonzalez-Dominguez, A
Meeting Abstract. 2020
Costs of the management of hemophilia A with inhibitors in Spain
Bonanad, S; (...); Gonzalez-Dominguez, A
Article. 10.33393/grhta.2021.2234. 2021
COVID vaccination among liver transplant recipients: A EASL-ESOT/ELITA-ILTS multi society survey
Vinaixa, Carmen; (...); Berenguer, Marina
Meeting Abstract. 2022
COVID vaccination among liver transplant recipients: an EASL-ESOT/ELITA-ILTS multi-society international survey
Vinaixa, C.; (...); Berenguer, M.
Meeting Abstract. 2022
COVID-19 and liver transplantation
Editorial Material. 10.1038/s41575-020-0347-z. 2020
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis
Megias-Vericat, JE; (...); Poveda, JL
Letter. 10.1111/hae.13733. 2019
Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products
Eduardo Megias, Juan; (...); Iorio, Alfonso
Meeting Abstract. 10.1182/blood-2019-127946. 2019
Cumulative exposure to tacrolimus and incidence of cancer after liver transplantation
Rodriguez-Peralvarez, Manuel; (...); Gomez Bravo, Miguel Angel
Meeting Abstract. 2022
Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.
Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL
Editorial Material. 10.1016/j.farma.2024.08.001. 2024
Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study
Aguilera, V; (...); Berenguer, M
Article. 10.1111/tri.13145. 2018
Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation
Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel
Meeting Abstract. 2023
CYTOMEGALOVIRUS SPECIFIC POLYFUNCTIONAL T-CELL RESPONSES EXPRESSING CD107A ASSOCIATED WITH CONTROL OF CMV REACTIVATION AFTER LIVER TRANSPLANTATION
Carvalho-Gomes, A; (...); Aguilera, V
Meeting Abstract. 2021
Cytomegalovirus specific polyfunctional T-cell responses expressing CD107a predict control of CMV infection after liver transplantation.
Carvalho-Gomes Â; (...); López-Labrador FX
Article. 10.1016/j.cellimm.2021.104455. 2022
Cytomegalovirus specific polyfunctional T-cells control CMV reactivation after liver transplantation
Carvalho-Gomes, A; (...); Aguilera, V
Meeting Abstract. 2021
Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation
Carvalho-Gomes, Angela; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2024
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
Marcos, AC; (...); Pons, JA
Meeting Abstract. 2021
Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients
Caballero-Marcos, A; (...); Pons, JA
Article. 10.1111/ajt.16599. 2021
Changing delta hepatitis patient profile: A single center experience in Valencia region, Spain
Hernandez-Evole, H, Briz-Redon, A, Berenguer, M
Article. 10.4254/wjh.v12.i6.277. 2020
Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin.
Mínguez Sabater A; (...); Berenguer, Marina
Article. 10.1016/j.gastrohep.2021.03.017. 2022
CHARACTERISTICS AND IMPACT OF SEX IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: A MULTICENTER STUDY FROM A CLASSICALLY LOW PREVALENCE AREA
Minguez, Alejandro; (...); Berenguer, Marina
Meeting Abstract. 2021
Characteristics and trends of liver transplantation in a cohort of patients with primary sclerosing cholangitis: a retrospective multicenter study
Minguez, A.; (...); Berenguer, M.
Meeting Abstract. 2022
Characteristics, trends and outcomes of liver transplantation (LT) for primary sclerosing cholangitis (PSC) in female patients: analysis of the European Liver Transplantation Registry (ELTR)
Di Maira, T; (...); European Liver & Intestine
Meeting Abstract. 2021
Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry
Berenguer M; (...); European Liver Intestine Transplan
Article. 10.1097/TP.0000000000003542. 2021
Characterizing chronic hepatitis delta in Spain and the gaps in its management
Rodriguez-Tajes, Sergio; (...); Lens, Sabela
Meeting Abstract. 2023
Characterizing Hepatitis Delta in Spain and the gaps in its management.
Rodriguez-Tajes, Sergio; (...); Lens, Sabela
Article. 10.1016/j.gastrohep.2024.502222. 2024
Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.1080/17512433.2019.1573668. 2019
Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2-Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019.
Caballero-Marcos, Aranzazu; (...); Salcedo, Magdalena
Article. 10.1002/lt.26389. 2022
Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure.
Chen Q; (...); Quer J
Article. 10.1016/j.antiviral.2019.104694. 2020
Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project
Blade, J; (...); Lizan, L
Article. 10.1136/bmjopen-2017-018850. 2018
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Ampuero, Javier; (...); Romero-Gomez, Manuel
Article. 10.1111/liv.14898. 2021
Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury
Medina-Caliz, I; (...); Spanish DILI Registry
Article. 10.1016/j.jhep.2016.05.003. 2016
Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting
Perricone, G; (...); European Liver Intestine Transpla
Article. 10.1111/liv.13878. 2018
Delisting of Liver Transplant Candidates with Chronic HCV Infection after Viral Erradication: Outcome 2 Years after Delisting. A European Study
Vinaixa, C; (...); Duvuox, C
Meeting Abstract. 10.1097/01.tp.0000542536.91165.49. 2018
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study
Belli LS; (...); European Liver and Intestine Association (ELITA)
Article. 10.1016/j.jhep.2016.05.010. 2016
Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study
Belli, LS; (...); Duvoux, C
Meeting Abstract. 10.1016/S0168-8278(17)30339-2. 2017
Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.
Salinas P; (...); Escaned J
Article. 10.1016/j.carrev.2021.11.015. 2021
Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis
Alvarez-Roman, MT; (...); Badia, X
Article. 10.1177/2284240319880534. 2019
DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Alvarez, E.; (...); Badia, F. J.
Meeting Abstract. 2019
Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
Abad, Maria Reyes; (...); Gil, Alicia
Article. 10.33393/grhta.2024.3041. 2024
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis
Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther
Article. 10.1002/jvc2.275. 2024
DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN
Poveda, J. L.; (...); Vitoria, I
Meeting Abstract. 2019
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis (vol 22, pg 2062, 2024)
De Vincentis, A.; (...); Conde, Isabel
Correction. 2025
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.
De Vincentis, Antonio; (...); Carbone, Marco
Article. 10.1016/j.cgh.2024.05.008. 2024
Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1111/liv.15766. 2024
Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain
Badia, X; (...); Poved, JL
Article. 10.1080/21678707.2019.1652163. 2019
Development and Validation of Hepamet Fibrosis Scoring System-a Simple, Non-invasive Test to Identify Patients With Nonalcoholic Fatty liver Disease With Advanced Fibrosis.
Ampuero J; (...); Del Pozo Maroto E
Article. 10.1016/j.cgh.2019.05.051. 2020
Diffusion tensor imaging as a prognostic biomarker for motor recovery and rehabilitation after stroke
Puig, J; (...); Pedraza, S
Review. 10.1007/s00234-017-1816-0. 2017
Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease.
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.3390/biom11121808. 2021
Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1111/apt.16100. 2021
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study
Manzardo, C; (...); FIPSE LT-HIV Investigators
Article. 10.1111/ajt.14996. 2018
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)
Manzardo, C.; (...); Samuel, D.
Article. 2018
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study (vol 18, pg 2513, 2018)
Manzardo, C.; (...); Samuel, D.
Correction. 10.1111/ajt.15244. 2019
Disease Reversibility in Patients With Post-Hepatitis C Cirrhosis: Is the Point of No Return the Same Before and After Liver Transplantation? A Review
Vinaixa, C, Strasser, SI, Berenguer, M
Review. 10.1097/TP.0000000000001633. 2017
Distinct features of hepatitis delta in a Mediterranean setting
Hernandez-Evole, H, Berenguer-Haym, M
Meeting Abstract. 10.1016/S0618-8278(19)30486-4. 2019
Does colectomy improve survival in patients with ulcerative colitis undergoing liver transplant for autoimmune liver diseases?
Trapero-Marugan, M.; (...); Cuervas-Mons, V.
Meeting Abstract. 2023
Does Surgeon Fatigue Influence the Results of Liver Transplantation?
Bosca, A; (...); Lopez-Andujar, R
Article. 10.1016/j.transproceed.2018.03.139. 2019
DRESS cases included in the Spanish and Latin-American DILI registries: clinical phenotype and outcome
Medina-Caliz, I; (...); Andrade, RJ
Meeting Abstract. 10.1016/S0168-8278(18)31459-4. 2018
Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases
Megias-Vericat, JE; (...); Poveda, JL
Review. 10.1007/s10072-017-2833-9. 2017
Early liver transplantation for acute alcoholic hepatitis In a spanish liver transplant center
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2023
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: A nationwide multicenter study
Tellez, Luis; (...); Albillos, Agustin
Article. 10.1111/apt.16926. 2022
Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation.
Cortesi, Paolo Angelo; (...); Belli, Luca Saverio
Article. 10.3389/ti.2023.10954. 2023
Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan
Ribera, E; (...); Hernandez-Novoa, B
Article. 10.1016/j.eimc.2016.11.015. 2018
Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.
Torres Martínez E; (...); Vento M
Article. 10.1016/j.anpedi.2020.03.009. 2020
Effect of season and sunlight on viral kinetics during hepatitis C virus therapy.
Hernandez-Alvarez, N; (...); Hernandez-Guerra, M
Article. 10.1136/bmjgast-2016-000115. 2017
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir +/- dasabuvir +/- ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection
Perello, C; (...); Spanish Collaborative Group for the Study of the Use of Hepatitis C Direct-Actin
Article. 10.1111/jvh.12637. 2017
EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT
Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado
Meeting Abstract. 2023
Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort
Alonso, S; (...); Fernandez-Rodriguez, CM
Article. 10.1111/jvh.12648. 2017
Effectiveness of 8 weeks of glecaprevir/pibrentasvir in treatment-naive hepatitis C patients with liver cirrhosis: results from the real-world Spanish Hepa-C registry
Turnes, Juan; (...); Perez Cachafeiro, Santiago
Meeting Abstract. 2020
Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment
Palanques-Pastor T; (...); Poveda Andrés JL
Article. 10.1159/000517813. 2021
Effectiveness of ribavirin use associated with direct-acting antivirals in the treatment of non-cirrhotic patients with genotype 1a or 4 HCV infection in real-world practice
Ruiz-Antoran, B; (...); Panero, JLC
Meeting Abstract. 10.1016/S0168-8278(17)31448-4. 2017
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
Calleja, JL; (...); Spanish Group for the Study of the Use of Direct-acting Drugs Hepatitis C Collab
Article. 10.1016/j.jhep.2017.01.028. 2017
Effectiveness, safety/tolerability of OBV/PTV/r DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.
Londoño MC; (...); García-Buey L
Article. 10.1371/journal.pone.0221567. 2019
Effectiveness, safety/tolerability of OBV/PTV/r +/- DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb/V and dialysis in Spanish clinical practice - preliminary data Vie-KinD study
Londono, MC; (...); De Alvaro, C
Meeting Abstract. 10.1016/S0168-8278(17)31920-7. 2017
Effects of high-resolution esophageal manometry on oxygen saturation and hemodynamic function
Ortiz, V; (...); Garrigues, V
Article. 10.1111/dote.12523. 2017
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study
Salcedo, M; (...); Bañares R
Article. 10.1111/tri.12999. 2017
Efficacy and safety of glecaprevir/pibrentasvir for the pangenotypic treatment of chronic hepatitis C in former intravenous drug users: Subanalysis from a Spanish real-world cohort (Hepa-C)
Puigvehi, M; (...); Carrion, JA
Meeting Abstract. 10.1016/S0618-8278(19)30399-8. 2019
Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation Cohort
Sanchez Antolin G; (...); Castells L
Article. 10.1016/j.transproceed.2016.08.034. 2016
Efficacy and tolerability of interferon-free antiviral therapy in kidney transplant recipients with chronic hepatitis C
Fernández I; (...); Londoño MC
Article. 10.1016/j.jhep.2016.12.020. 2017
EFFICACY OF OBETICHOLIC ACID (OCA) VS PLACEBO AND EXTERNAL CONTROL (EC) ON CLINICAL OUTCOMES IN PRIMARY BILIARY CHOLANGITIS (PBC)
Kowdley, Kris V.; (...); Villamil, Alejandra
Meeting Abstract. 2023
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study
Forns, X; (...); Jessner, W
Article. 10.1111/tid.12696. 2017
Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study.
Forns, Xavier; (...); Jessner, Wolfgang
Article. 2017
eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice
Bonanad, S; (...); Megias-Vericat, JE
Meeting Abstract. 2018
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)
Crespo, J; (...); Antolin, GS
Article. 10.17235/reed.2019.6700/2019. 2019
Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH).
Crespo J; (...); Sánchez Antolín G
Article. 10.1016/j.gastrohep.2019.09.002. 2019
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients
Belli, LS; (...); Strazzabosco, M
Review. 10.1016/j.jhep.2017.03.006. 2017
ELITA consensus statements on use of DAAs in liver transplant candidates and recipients.
Belli, Luca S; (...); ELITA board members
Guideline. 2017
Enhanced recovery after surgery programs improve short-term outcomes after liver transplantation-A systematic review and meta-analysis
Tinguely, Pascale; (...); Spiro, Michael
Article. 10.1111/ctr.14453. 2021
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society consensus conference.
Pollok, Joerg M.; (...); Spiro, Michael
Article. 10.1016/S2468-1253(22)00268-0. 2023
Epidemiological pattern, incidence and outcomes of COVID-19 in liver transplant patients.
Colmenero J; (...); Pons JA
Article. 10.1016/j.jhep.2020.07.040. 2021
Equally Interchangeable? How Sex and Gender Affect Transplantation
Melk, A; (...); Berenguer, M
Review. 10.1097/TP.0000000000002655. 2019
Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25).
Ampuero J; (...); Romero-Gómez M
Correction. 10.1016/j.jhep.2020.06.018. 2020
Ertapenem neurotoxicity in liver transplantation.
Martinez Delgado, Sara; (...); Conde, Isabel
Article. 10.17235/reed.2021.8469/2021. 2022
ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process.
Cillo U; (...); Selzner N
Review. 10.3389/ti.2022.10915. 2022
European and American Temporal Trends and Outcomes in Liver Transplant (LT) Patients with Human Immunodeficiency Virus (HIV)
Campos-Varela, I; (...); Terrault, N
Meeting Abstract. 2017
European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.
Berenguer M; (...); Zubair H
Article. 10.3389/ti.2023.11358. 2023
EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN
Badia, F. J.; (...); Shepherd, J.
Meeting Abstract. 2019
Evaluation and Management of Liver Transplant Candidates With Prior Nonhepatic Cancer: Guidelines From the ILTS/SETH Consensus Conference.
Salcedo, Magdalena; (...); Line, Pal-Dag
Article. 10.1097/TP.0000000000003997. 2022
Everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled study.
Gómez-Bravo M; (...); Santoyo J
Article. 10.17235/reed.2022.8549/2021. 2022
Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study
Gustot, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2024
Exchangeable copper for patients with Wilson disease at follow-up: rethinking normal ranges or changing methodology.
Marino, Zoe; (...); Berenguer, Marina
Article. 10.1097/HEP.0000000000001105. 2024
EXCHANGEABLE COPPER QUANTIFICATION FELLS BELOW NORMAL RANGE IN A HIGH PROPORTION OF PATIENTS WITH WILSON DISEASE DURING FOLLOW-UP
Mendez, Zoe Marino; (...); Berenguer, Marina
Meeting Abstract. 2024
Exchangeable copper quantification fells belownormal range in a high proportion of patients withWilson disease during follow-up
Marino, Zoe; (...); Berenguer, Marina
Meeting Abstract. 2024
Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management
Jadoul, M; (...); Martin, P
Article. 10.1016/j.kint.2018.06.011. 2018
Experience of Home Delivery Program in Haemophilia Through an Association of Patients
Megias Vericat, J. E.; (...); Bonanad Boix, S.
Meeting Abstract. 2017
EXPERT CONSENSUS CRITERIA AND PRACTICAL RECOMMENDATIONS FOR PBC CARE IN THE COVID-19 ERA AND BEYOND
Berenguer, Marina; (...); Carbone, Marco
Meeting Abstract. 2021
Exploratory analysis for the implementation of antineoplastic logarithmic dose banding
Albert-Mari, A; (...); Poveda-Andres, JL
Article. 10.1007/s11096-018-0714-9. 2018
Exploring pregnancy, breastfeeding and contraception among women with Wilson disease in Spain: results from the Spanish Wilson registry
Romero-Gutierrez, Marta; (...); Marino, Zoe
Meeting Abstract. 2023
EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY
F, de Andres-Nogales; (...); Martinez, M.
Meeting Abstract. 2019
External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients
Sahuco, Ivan; (...); Berenguer, Marina
Meeting Abstract. 2023
External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.
Carvalho-Gomes Â; (...); Berenguer M
Article. 10.1002/ueg2.12571. 2024
Fat and liver transplantation: clinical implications
Vinaixa, C, Selzner, N, Berenguer, M
Review. 10.1111/tri.13288. 2018
Fat, cancer, the gut-liver axis and rare liver diseases.
Editorial Material. 10.1016/j.jhepr.2020.100189. 2020
Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease
Beltran, B; (...); Nos, P
Article. 10.1159/000492626. 2019
Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report
Fernandez-Sanchez, M; (...); Poveda-Andres, JL
Article. 10.1002/bdr2.1942. 2021
FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
Martinez-Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2024
FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2024
FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.
Martinez-Arenas, Laura; (...); Berenguer, Marina
Article. 10.1111/liv.16085. 2024
First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs
Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis
Meeting Abstract. 2023
Frailty and Sarcopenia in Acute-on-Chronic Liver Failure
Renau, LP; (...); Berenguer M
Article. 10.1002/hep4.1722. 2021
Frailty changes after liver transplantation in the Spanish setting. Results from a Spanish multicentre prospective cohort study
Puchades, L.; (...); Berenguer, M.
Meeting Abstract. 2023
Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort Study
Puchades, Lorena; (...); Berenguer, Marina
Article. 10.1097/TXD.0000000000001599. 2024
GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study.
Rodríguez-Perálvarez ML; (...); Gastaca M
Article. 10.1016/j.eclinm.2024.102737. 2024
GENDER AND RACIAL DISCRIMINATION AMONG LIVER TRANSPLANTATION PROFESSIONALS: A SURVEY FROM ILTS EDI COMMITTEE
Andacoglu, Oya; (...); Selzner, Nazia
Meeting Abstract. 2021
Gender and racial discrimination among liver transplantation professionals: report of a global survey
Aguilera, V.; (...); Selzner, N.
Article. 2022
Gender and Racial Disparity Among Liver Transplantation Professionals: Report of a Global Survey
Aguilera, Victoria; (...); Selzner, Nazia
Article. 10.3389/ti.2022.10506. 2022
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, Isabel; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, I.; (...); Aguilera, V.
Meeting Abstract. 2023
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.
Plaza J; (...); Moret-Tatay I
Article. 10.3390/ijms25073717. 2024
Genetics of Wilson disease and Wilson-like phenotype in a clinical series from eastern Spain.
Sánchez-Monteagudo A; (...); Espinós C
Article. 10.1111/cge.13719. 2020
Good posttransplant outcome using donors after cardiac death (DCD) when applying strict selection criteria
de la Varga, MF; (...); Castillo, MP
Meeting Abstract. 2021
Good post-transplant outcomes using liver donors after circulatory death when applying strict selection criteria: A propensity-score matched-cohort study.
Fernandez-de la Varga, Margarita; (...); Aguilera, Victoria
Article. 10.1016/j.aohep.2022.100724. 2022
Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis
Editorial Material. 2022
Guidelines on treatment of hepatitis C virus infection. Spanish Association for the Study of the Liver (AEEH)
Calleja, JL; (...); Pineda, JA
Article. 10.1016/j.gastrohep.2018.07.010. 2018
Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12568. 2017
Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study
Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units
Article. 10.7399/fh.10935. 2018
HCV cirrhosis: liver volume as a non-invasive predictor of liver recovery post DAA treatment
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 10.1016/S0168-8278(17)31568-4. 2017
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Solana-Altabella, Antonio; (...); Martinez-Cuadron, David
Article. 10.3390/cancers14081921. 2022
Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study.
Marino, Zoe; (...); Anguera, Anna
Article. 10.3390/jcm12144823. 2023
Heat stroke and fulminant hepatitis: Conservative management or liver transplant?
Ladrón Abia P; (...); Berenguer Haym MC
Letter. 10.1016/j.gastrohep.2020.11.004. 2021
Hepamet Score: a new non-invasive method for NAFLD-related fibrosis screening in clinical practice
Ampuero, J; (...); Gomez, MR
Meeting Abstract. 10.1016/S0168-8278(18)30415-X. 2018
Hepatic nerve endings are rewired by cholestatic injury to connect inflamed lymphatics to sites of ductular remodelling
Noon, Luke; (...); Lloyd, Alison
Meeting Abstract. 2023
Hepatic steatosis and steatohepatitis: a functional meta-analysis of sex-based differences in transcriptomic studies
Catala-Senent, Jose F.; (...); Garcia-Garcia, Francisco
Article. 10.1186/s13293-021-00368-1. 2021
Hepatitis B surface antigen loss after discontinuing nucleos(t)ide analogue for treatment of chronic hepatitis B patients is persistent in White patients
Suarez, E; (...); Simon, MA
Article. 10.1097/MEG.0000000000001289. 2019
Hepatitis C-related cirrhosis: Current status
Conde, I, Vinaixa, C, Berenguer, M
Review. 10.1016/j.medcli.2016.09.019. 2017
Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19
Del Hoyo, J.; (...); Aguilera, V
Editorial Material. 2020
Hepatobiliary and Pancreatic: A fatal case of extensive splanchnic vein thrombosis in a patient with Covid-19.
Del Hoyo J; (...); Aguilera V
Editorial Material. 10.1111/jgh.15174. 2020
HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity
Andrade, Rita; (...); Cardoso, Joana
Article. 10.3390/cancers17030500. 2025
Hepatorenal syndrome markedly impacts prognosis of patients with alcohol-associated hepatitis. Results from the spanish registry of alcohol-associated liver disease (REHALC)
Gratacos-Gines, Jordi; (...); Pose, Elisa
Meeting Abstract. 2024
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4
Mariño Z; (...); Forns, X
Article. 10.1111/liv.13470. 2017
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.
El-Qutob D; (...); Carrera-Hueso FJ
Article. 10.1016/j.hrtlng.2022.02.003. 2022
High-permeability region size on perfusion CT predicts hemorrhagic transformation after intravenous thrombolysis in stroke
Puig, J; (...); Castellanos, M
Article. 10.1371/journal.pone.0188238. 2017
HIV infection is not associated with increased cardiovascular (CV) risk in liver transplant (LT) recipients: a single centre comparative study
Vinaixa, C.; (...); Prieto, M.
Meeting Abstract. 2019
HIV Infection Is Not Associated with Increased Cardiovascular Risk in Liver Transplant Recipients: A Single Center Comparative Study
Herreras, J; (...); Berenguer, M
Meeting Abstract. 2018
Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies
Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo
Article. 10.7399/fh.11729. 2022
Hospitalization budget impact during the COVID-19 pandemic in Spain.
Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.
Article. 10.1186/s13561-021-00340-0. 2021
How can artificial intelligence optimize value-based contracting?
Poveda, Jose Luis; (...); Medrano, Ignacio H.
Letter. 10.1186/s40545-022-00475-3. 2022
Human immunodeficiency virus-infected liver transplant recipients with incidental hepatocellular carcinoma: A prospective multicenter nationwide cohort study
Aguero, F; (...); FIPSE Investigators
Article. 10.1002/lt.24741. 2017
Hydrogen Sulfide Improves Cardiomyocyte Function in a Cardiac Arrest Model
Garcia, NA; (...); Sepulveda, P
Article. 10.12659/AOT.901410. 2017
Iberogast-Induced Severe Hepatotoxicity Leading to Liver Transplantation
Sáez-González E; (...); Berenguer M
Letter. 10.1038/ajg.2016.260. 2016
IDENTIFICATION OF CANDIDATES FOR MASLD TREATMENT WITH INDETERMINATE VIBRATION- CONTROLLED TRANSIENT ELASTOGRAPHY
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2024
Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography.
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Article. 10.1016/j.cgh.2024.10.014. 2024
Immunogenicity of COVID-19 vaccines in lung cancer patients.
Provencio M; (...); Calvo V
Article. 10.1016/j.lungcan.2023.107323. 2023
Immunosuppression in liver transplant.
Di Maira T, Little EC, Berenguer M
Review. 10.1016/j.bpg.2020.101681. 2020
Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1080/10428194.2016.1231405. 2017
Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis
Edo Solsona MD; (...); Poveda Andrés JL
Article. 10.2147/PPA.S127508. 2017
IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART (R) IN PATIENTS WITH MULTIPLE SCLEROSIS
Edo-Solsona, M.; (...); Poveda-Andres, J.
Meeting Abstract. 10.1016/j.jval.2016.09.512. 2016
Impact of an antimicrobial stewardship program on critical haematological patients.
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.7399/fh.2017.41.4.10709. 2017
Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1080/10428194.2020.1839650. 2020
IMPACT OF COMORBIDITIES ON LIVER TRANSPLANTATION: A PROSPECTIVE AND MULTICENTRIC ANALYSIS
Serrano, Trinidad; (...); Salcedo, Magdalena
Meeting Abstract. 2023
Impact of comorbidities on liver transplantation: a prospective and multicentric study
Serrano, Trinidad; (...); Salcedo, Magdalena
Meeting Abstract. 2022
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: an updated EASL position paper.
Marjot, Thomas; (...); Cornberg, Markus
Article. 10.1016/j.jhep.2022.07.008. 2022
Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT)
Saez-Gonzalez, E; (...); Berenguer, M
Article. 10.1111/liv.13618. 2018
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
Beumer, Berend R.; (...); IJzermans, Jan N. M.
Article. 10.1002/jcsm.13053. 2022
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
Beumer, Berend; (...); Ijzermans, Jan
Meeting Abstract. 10.1002/jcsm.13053. 2022
Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1038/tpj.2017.19. 2018
Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1097/FPC.0000000000000286. 2017
Impact of obesity on transient elastography accuracy among patients with non-alcoholic fatty liver disease
Del Barrio Azaceta, Maria; (...); Crespo, Javier
Meeting Abstract. 2023
Impact of suffering Wilson disease in Spain: an observational cross-sectional multicenter study
Marino, Zoe; (...); Anguera, Anna
Meeting Abstract. 2023
Impact of the alveolar-arterial oxygen gradient on prognosis after liver transplantation in adults: a single-center experience
Ortega, AG; (...); Reyes, RL
Meeting Abstract. 10.1183/13993003.congress-2020.1917. 2020
Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019
Badia X; (...); Hernández C
Article. 10.1186/s13023-020-01507-4. 2020
Impact of voriconazole plasma concentrations on treatment response in critically ill patients
Ruiz, J; (...); Ramirez, P
Article. 10.1111/jcpt.12817. 2019
Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases
Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL
Article. 10.7399/fh.11262. 2020
Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients
Ruiz-Ramos, J; (...); Ramirez, P
Article. 10.1159/000478969. 2018
Inadequate social support decreases survival in decompensated liver cirrhosis patients.
García Morales N; (...); Cubiella, Joaquin
Article. 10.1016/j.gastrohep.2022.04.006. 2022
Incidence and prognostic impact of cancer after liver transplantation
Gastaca, M; (...); Rodriguez-Peralvarez, M
Meeting Abstract. 2021
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2023
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, I. Terol; (...); Sancho-Tello, M. V. Aguilera
Meeting Abstract. 2023
Increased cardiovascular risk post-LT in HIV-infected patients? An ELTR based multicenter study
Vinaixa, C.; (...); Aguilera, M. V.
Meeting Abstract. 2024
Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A
Vericat, JEM; (...); Bonanad, S
Meeting Abstract. 2018
Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables
Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago
Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016
Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy
Bastida, G; (...); Nos, P
Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019
Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment
Megias-Vericat, JE; (...); Aliño SF
Article. 10.1080/10428194.2017.1323267. 2017
Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.
Ruiz J; (...); Poveda JL
Article. 10.23736/S0026-4946.18.04978-2. 2018
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.
Megías-Vericat JE; (...); Montesinos P
Article. 10.1097/FPC.0000000000000431. 2021
Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3 months and at 5 years
Ramos-Prol, A.; (...); Merino-Torres, J. F.
Article. 10.1007/s40618-017-0810-z. 2018
Interdisciplinary recommendations document to improve adherence in patients with chronic inflammatory diseases: Adhing recommendations.
Bermejo San José F; (...); Sanromán-Álvarez L
Article. 10.7399/fh.2016.40.5.10180. 2016
Interferon-free therapy is effective and safe for hepatitis C recurrence in liver transplant hepatitis C virus/human immunodeficiency virus coinfected recipients: a case-control study
Londono, MC; (...); FIPSE Investigators
Meeting Abstract. 10.1016/S0168-8278(17)30669-4. 2017
International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation
Tsochatzis, E; (...); Berenguer, M
Review. 10.1097/TP.0000000000002433. 2019
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates
Terrault, NA; (...); Berenguer, M
Review. 10.1097/TP.0000000000001708. 2017
International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients
Terrault, NA; (...); McCaughan, GW
Review. 10.1097/TP.0000000000001704. 2017
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients
Charlton, M; (...); Saliba, F
Review. 10.1097/TP.0000000000002147. 2018
International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients (vol 102, pg 727, 2018)
Correction. 10.1097/TP.0000000000002535. 2019
International Liver Transplantation Society Global Census report: a first look at the pediatric liver transplantation activity around the world
Lopez-Verdugo, F; (...); Pediat Liver Transplantation
Meeting Abstract. 2021
International Living Donor Liver Transplant Registry - Initial progress towards transparent reporting of outcomes
Kantsedikas, I.; (...); Rela, M.
Meeting Abstract. 2024
Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report
Company-Albir, MJ; (...); Poveda, JL
Article. 10.1111/jcpt.12842. 2019
Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.
Solana-Altabella A; (...); Poveda JL
Article. 10.1177/1078155220904410. 2020
Introduction to hepatitis C virus infection: Overview and history of hepatitis C virus therapies
Puchades Renau, L, Berenguer, M
Review. 10.1111/hdi.12647. 2018
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19
Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP
Article. 10.1136/ejhpharm-2020-002322. 2020
Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.
Pozo-Rosich P; (...); Irimia P
Article. 10.1186/s10194-024-01747-w. 2024
Is hepatitis B immunoglobulin necessary for hepatitis D prophylaxis after liver transplantation? A retrospective multicenter study of a cohort of 174 patients
Rodriguez-Tajes, Sergio; (...); Forns, Xavier
Meeting Abstract. 2020
Is there a variation of CA-125 levels with changes in glomerular filtration rate in patients with heart failure?
Carrillo, D; (...); Almenar, L
Meeting Abstract. 2018
Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.
Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula
Article. 10.3390/antibiotics13080706. 2024
Kinetics of Cytomegalovirus Specific Polyfunctional T-Cell Responses Associated with Control of CMV Reactivation after Liver Transplantation.
Carvalho-Gomes, A; (...); Lopez-Labrador, FX
Meeting Abstract. 2018
Last Gasps of the Hepatitis C Virus Dragon: Direct Acting Antiviral Failures and Hepatitis C Virus-Positive Donors
Article. 10.1002/lt.24520. 2016
LATTICE radiotherapy: A one institution experience
Solero, I.; (...); Conde, A.
Meeting Abstract. 2023
Launch of the International Living Donor Liver Transplantation Outcomes Registry.
Staubli, Sebastian; (...); Rela, Mohamed
Letter. 10.1016/S2468-1253(23)00185-1. 2023
Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes
Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis
Meeting Abstract. 2023
LIPID DROPLET MORPHOLOGY JUSTIFIES DISCORDANCES BETWEEN HEPATIC STEATOSIS GRADES AND MRI PROTON DENSITY FAT FRACTION
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2024
Liver transplant for porto-sinusoidal vascular disease (psvd): long-term outcome
Magaz, M; (...); Valdig
Meeting Abstract. 2021
Liver Transplantation 2023: Status Report, Current and Future Challenges.
Terrault, Norah A; (...); Heimbach, Julie
Article. 10.1016/j.cgh.2023.04.005. 2023
LIVER TRANSPLANTATION FOR NON-ALCOHOLIC STEATOHEPATITIS: LOW PREVALENCE REGIONS ARE CATCHING UP
Martinez Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2022
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: Results of the ELITA/EF-CLIF collaborative study (ECLIS)
Belli, LS; (...); ELITA EF-CLIF Working Grp
Article. 10.1016/j.jhep.2021.03.030. 2021
Liver Transplantation for Porto-Sinusoidal Vascular Liver Disorder: Long-term Outcome.
Magaz, Marta; (...); Garcia-Pagan, Juan Carlos
Article. 10.1097/TP.0000000000004444. 2022
Liver volume as a predictor of functional improvement post DAA treatment
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 2017
Liver Volume as a Predictor of Functional Improvement Post-DAA Treatment
Di Maira, T; (...); Berenguer, M
Article. 10.1097/TP.0000000000001990. 2018
Liver Volume as a Predictor of Outcome after HCV Eradication in Cirrhotic Patients
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 2017
LOCATION AND ALLOCATION: INEQUITY OF ACCESS TO LIVER TRANSPLANTATION FOR PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE GRADE 3 (ACLF-3) ACROSS EUROPE.
Artzner, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2021
Location and allocation: inequity of access to liver transplantation for patients with severe acute-on-chronic liver failure in Europe.
Artzner, Thierry; (...); Jalan, Rajiv
Article. 10.1002/lt.26499. 2022
Long term follow-up in HCV infected patients with end stage chronic kidney disease after DAA therapy
Martinez-Camprecios, J; (...); Buti, M
Meeting Abstract. 2021
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.
Gomez, E; (...); Fernandez-Rodriguez, C M
Article. 10.1111/apt.18004. 2024
Long-term Challenges After Solid Organ Transplantation: Summary of Expert Presentations From the Sandoz 5th Standalone Transplantation Meeting, 2017.
Legendre C; (...); Guthoff M
Article. 10.1097/TP.0000000000002316. 2018
Long-Term Effectiveness, Safety, and Patient- Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
Roche B; (...); Samuel D
Article. 10.12659/AOT.936162. 2022
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapy
Martinez-Camprecios, Joan; (...); Buti, Maria
Article. 10.1016/j.gastrohep.2022.12.004. 2023
Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry.
Heinemann M; (...); all the other contributing centers (www.eltr.org) and the European Liver and Int
Article. 10.1111/ajt.16864. 2022
Long-term outcomes of the octogenarian donor liver recipient: The era of the new centurion.
Schneider S; (...); Berenguer M
Article. 10.1111/ctr.13629. 2019
Long-term patient and graft survival after liver transplantation for autoimmune hepatitis
Heinemann, Melina; (...); Schramm, Christoph
Meeting Abstract. 2020
Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates
Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado
Meeting Abstract. 2023
Long-term survival after liver transplantation for autoimmune hepatitis - results from the European Liver Transplant Registry.
Heinemann M; (...); Schramm C
Article. 10.1002/lt.25739. 2020
Long-term survival after living donor liver transplantation in primary sclerosing cholangitis
Liwinski, T; (...); Schramm, C
Meeting Abstract. 2021
Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.
Alonso-Castellano, Pablo; (...); Garcia-Villarreal, Luis
Article. 10.1016/j.dld.2024.09.002. 2024
MAGNETIC RESONANCE IMAGING-BASED BIOMARKER ACCURATELY IDENTIFIES PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND CLINICALLY SIGNIFICANT LIVER FIBROSIS: A MULTICENTER, INTERNATIONAL, VALIDATION STUDY
Arnouk, Joud; (...); Marti-Bonmati, Luis
Meeting Abstract. 2021
Magnetic resonance imaging-based biomarker accurately identifies patients with nonalcoholic steatohepatitis and significant liver fibrosis: a multicentre, international, validation study
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2022
Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry
Marino, Zoe; (...); Castillo, Pilar
Meeting Abstract. 2023
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.
Ruiz-Arabi, Elisa; (...); Aguado, Jose Maria
Article. 10.1016/j.trre.2024.100875. 2024
Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Kirchner, Varvara A.; (...); Rela, Mohamed
Article. 10.1097/TP.0000000000004771. 2023
Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.
Megías-Vericat JE; (...); Poveda-Andrés JL
Article. 2021
Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.
Vázquez Polo A; (...); Vázquez Costa JF
Article. 10.20960/nh.03946. 2022
Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A
Bonanad, S; (...); Santos, S
Article. 10.1007/s12325-021-01853-0. 2021
Metabolic and biochemical phenotypes can distinguish different patterns of histological severity in biopsy-proven NAFLD
Gomez, EV; (...); Romero-Gomez, M
Meeting Abstract. 10.1016/S0168-8278(17)30584-6. 2017
Metabolic dysfunction-associated fatty liver disease increases cardiovascular risk regardless of classical risk factors
Del Barrio Azaceta, Maria; (...); Crespo, Javier
Meeting Abstract. 2022
Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Article. 10.3390/cancers14030596. 2022
Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcomes?
Herreras Lopez, Julia; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8384/2021. 2022
Metabolically unhealthy status impacts on the risk of significant liver injury in biopsy-proven NAFLD patients beyond obesity
Ampuero, J; (...); Gomez, MR
Meeting Abstract. 10.1016/S0168-8278(18)31941-X. 2018
Metyrapone as treatment in the neonatal McCune-Albright syndrome
de Mingo, Carmen; (...); Garcia-Robles, Ana
Article. 10.1515/jpem-2020-0036. 2020
Milan-out Criteria and Worse Intention-to-Treat Outcome Postliver Transplantation.
Herreras J; (...); Berenguer M
Article. 10.1097/TXD.0000000000000934. 2019
Mitochondrial bioenergetics boost macrophages activation promoting liver regeneration in metabolically compromised animals.
Goikoetxea-Usandizaga, Naroa; (...); Martínez-Chantar ML
Article. 10.1002/hep.32149. 2021
Monitoring coagulation factors during surgery. A systematic review
Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11766. 2021
Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).
Valero-García S; (...); Delgado-Sánchez O
Article. 10.7399/fh.11655. 2021
Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.
Fernandez-Megia, MJ; (...); Poveda Andrés JL
Article. 10.7399/fh.10793. 2018
MORE THAN A THIRD OF UNTREATED PATIENTS WITH CHRONIC HEPATITIS DELTA HAVE A DECREASE OR REACH UNDETECTABLE LEVELS OF HDV-RNA DURING NATURAL HISTORY
Palom, A; (...); Ferret, MAB
Meeting Abstract. 2020
Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort.
Serrano MT; (...); Salcedo M
Article. 10.3389/ti.2022.10263. 2022
MRI-PDFF captures the whole spectrum of lipid composition beyond traditional histological evaluation of macrosteatosis
Marti-Aguado, David; (...); Marti-Bonmati, Luis
Meeting Abstract. 2023
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels).
Riveiro-Barciela, Mar; (...); Esteban, Rafael
Article. 10.1016/j.gastrohep.2023.01.010. 2023
Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease
Bruguera M; (...); Mariño Z
Editorial Material. 10.1016/j.gastrohep.2016.06.003. 2016
Multidisciplinary units in tertiary referral hospitals to improve management of Wilson disease (vol 39, pg 571, 2016)
Bruguera, M; (...); Mariño Z
Correction. 10.1016/j.gastrohep.2017.02.005. 2017
Multidrug resistant bacterial infections after liver transplantation: prevalence, impact and associated risk factors
Martin-Mateos, Rosa; (...); Albillos, Agustin
Meeting Abstract. 2022
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors
Martin-Mateos, R.; (...); Albillos, A.
Meeting Abstract. 2024
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.
Martin-Mateos R; (...); Albillos A
Article. 10.1016/j.jhep.2024.02.023. 2024
Multidrug-resistant bacterial infections in patients with liver cirrhosis in a tertiary referral hospital
Bejar-Serrano, S; (...); Benlloch, S
Article. 10.1016/j.gastrohep.2018.07.017. 2019
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
Deek MP; (...); Sweeney C
Article. 10.1016/j.euo.2024.03.010. 2024
Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
Gomez-Cebrian, N; (...); Pineda-Lucena, A
Review. 10.3390/cancers13184544. 2021
National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)
Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel
Correction. 10.7399/fh.11740. 2021
National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies
Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis
Meeting Abstract. 10.1182/blood-2022-169938. 2022
New challenges of advanced therapies.
Megías-Vericat JE; (...); Poveda Andrés JL
Article. 10.1016/j.farma.2023.11.008. 2024
New ERAS in liver transplantation - Past, present, and next steps
Hannon, Vivienne N.; (...); ERAS4OLT Org Working Grp
Article. 10.1111/ctr.14625. 2022
Non-alcoholic steatohepatitis as liver transplant indication: similarities and differences between a high and a low prevalence countries
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2022
Non-alcoholic steatohepatitis is also becoming a major liver transplant indication in Spain, a historically low risk area
Martinez-Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2022
Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers
Lopez-Riera, M; (...); Jover, R
Article. 10.1038/s41598-018-28854-4. 2018
Noninvasive Prediction of Outcomes in Autoimmune Hepatitis-Related Cirrhosis.
Llovet, Laura-Patricia; (...); Londoño MC
Article. 10.1002/hep4.1889. 2022
Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt-TIPS, and strategies to improve the outcomes
Review. 10.51821/86.2.11430. 2023
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
Reig, A; (...); Pares, A
Article. 10.14309/ajg.0000000000001343. 2021
Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis
Article. 10.1097/MD.0000000000032208. 2022
ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.
Poveda JL; (...); Badia X
Article. 10.1186/s13023-022-02610-4. 2023
Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes
Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor
Review. 10.3390/biology12091159. 2023
One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease
Palom, A; (...); Buti, M
Article. 10.1111/apt.16485. 2021
Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice
Bonanad, S; (...); Poveda, JL
Meeting Abstract. 2018
Open wound and cutaneous fistulization after microwave ablation of hepatocarcinoma.
Ladron Abia, Pablo; (...); Aguilera, Victoria
Article. 10.17235/reed.2022.8663/2022. 2022
Optimal management of perioperative analgesia regarding immediate and short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert panel recommendations
Sun, Li-Ying; (...); ERAS4OLT Org Working Grp
Review. 10.1111/ctr.14640. 2022
Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry
Fernandez-Gordon Sanchez, Flor M.; (...); Gomez-Dominguez, Elena
Meeting Abstract. 2024
OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT
Flores-Moreno, S.; (...); Gil, A.
Meeting Abstract. 2024
Out of Milan criteria and worse intetion to treat results at large liver transplant center
Lopez, JH; (...); Haym, MB
Meeting Abstract. 10.1016/S0168-8278(18)30613-5. 2018
Outcome of liver transplant candidates "delisted" after successful treatment of HCV infection
Perricone, G; (...); ELITA
Meeting Abstract. 2018
Out-of-Milan criteria and worse intention-to-treat results at a large liver transplant (LT) centre
Herreras, J; (...); Berenguer, M
Meeting Abstract. 2018
Out-of-Milan HCC criteria and worse intention-to-treat results following liver transplantation
Herreras, J.; (...); Berenguer, M.
Meeting Abstract. 2019
OVERCOMING BARRIERS TO CARE FOR DELTA INFECTED PATIENTS
Carvalho-Gomes, Angela; (...); Berenguer, Marina
Meeting Abstract. 2022
Overcoming barriers to care for Delta infected patients
Bono, Ariadna; (...); Berenguer, Marina
Meeting Abstract. 2023
Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease.
Marques, Patrice; (...); Sanz, Maria-Jesus
Article. 10.3390/ijms24032313. 2023
Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
Pilar Ballester, Maria; (...); Nicastro, Emanuele
Meeting Abstract. 2024
Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.
Marti-Aguado D; (...); Marti-Bonmati L
Article. 10.3389/fendo.2023.1213441. 2023
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol
Garcia-Robles, Ana; (...); Carrascosa, MA
Article. 10.3389/fped.2020.00372. 2020
Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Correction. 10.3389/fped.2021.834454. 2022
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project
Morillo-Verdugo, R; (...); Diaz-Olmo, J
Article. 10.7399/fh.11719. 2021
Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.
Morillo-Verdugo R; (...); Díaz-Olmo J
Article. 2021
Performance of the OraQuick Hepatitis C virus antibody test in oral fluid and fingerstick blood before and after treatment-induced viral clearance
Pallares, C; (...); Lopez-Labrador, FX
Article. 10.1016/j.jcv.2018.02.016. 2018
Periesophageal Lymph Node Metastasis of Prostate Adenocarcinoma From Liver Transplant Donor
Sanchez-Montes, C; (...); Arguello, L
Editorial Material. 10.14309/ajg.0000000000000135. 2019
Periodontal disease and gestational diabetes mellitus: a case-control study
Estevez Llorens, R.; (...); Perales Marin, A.
Article. 10.1016/j.gine.2021.100675. 2021
Peritransplant Antiviral Treatment of Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients
Vinaixa, C; (...); Prieto, M
Letter. 10.1002/lt.25297. 2018
Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant
Editorial Material. 10.5604/16652681.1235470. 2017
Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy
Margusino-Framiñán L; (...); Morillo-Verdugo R
Article. 10.7399/fh.11498. 2020
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis
Article. 10.3390/ijms26041760. 2025
Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia
Megias-Vericat, JE; (...); Montesinos, P
Review. 10.2174/1389200218666171101124931. 2018
Pharmacometabolomics by NMR in Oncology: A Systematic Review.
Gómez-Cebrián N; (...); Pineda-Lucena A
Article. 10.3390/ph14101015. 2021
Pharmacotherapeutic management of advanced therapy medicinal products
Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia
Article. 10.7399/fh.13036. 2022
Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.
Calleja Hernández MÁ; (...); Aragon, B
Article. 10.7399/fh.2017.41.1.10463. 2017
Physical Activity In Haemophilia: Hemorrhagic Risk And Factor Levels (myPKFiT)
Querol-Fuentes, F; (...); Bonanad, S
Meeting Abstract. 2017
PHYSICAL FRAILTY IN LIVER TRANSPLANTATION.
Puchades Renau L; (...); Berenguer Haym M
Review. 10.17235/reed.2020.7448/2020. 2021
Pilot evaluation of home delivery programme in haemophilia
Megias-Vericat, JE; (...); Poveda-Andres, JL
Article. 10.1111/jcpt.12718. 2018
Pilot validation study of a rapid test in oral fluid for population screening of hepatitis C virus infection
Pallares, C; (...); Berenguer, M
Meeting Abstract. 10.1016/S0168-8278(17)31165-0. 2017
PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS
Vericat, JEM; (...); Iorio, A
Meeting Abstract. 2020
Population screening using a point-of-care test reveals unexpectedly low prevalence of active HCV infection in Spain
Carvalho-Gomes, A; (...); Berenguer, M
Meeting Abstract. 2017
Porto sinusoidal vascular liver disorder: natural history and long-term outcome
Magaz, Marta; (...); Garcia Pagan, Juan Carlos
Meeting Abstract. 2023
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome.
Magaz, Marta; (...); Garcia-Pagan, Juan Carlos
Article. 10.1016/j.jhep.2024.07.035. 2024
Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Kow, Alfred Wei Chieh; (...); Ikegami, Toru
Article. 10.1097/TP.0000000000004770. 2023
Posttransplant Management of Recipients Undergoing Liver Transplantation for Hepatocellular Carcinoma. Working Group Report From the ILTS Transplant Oncology Consensus Conference
Berenguer, M; (...); van der Laan, LJW
Review. 10.1097/TP.0000000000003196. 2020
Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Castelló B; (...); Berenguer M
Article. 10.1016/j.aohep.2019.06.014. 2019
Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process
Valero, S; (...); Poveda, JL
Article. 10.1016/j.yrtph.2018.03.001. 2018
PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS)
De Vincentis, Antonio; (...); Carbone, Marco
Meeting Abstract. 2023
Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.
Ampuero J; (...); Fernández-Rodríguez C
Article. 10.1097/HEP.0000000000000826. 2024
Predictive factors of response to corticosteroid therapy in acute severe autoinmune hepatitis: a national multicentric study
Sanchez Rodriguez, Eugenia; (...); Albillos, Agustin
Meeting Abstract. 2020
Pregnancy and autoimmune hepatitis: presentation and outcomes
Llovet, LP; (...); Londono, MC
Meeting Abstract. 10.1016/S0168-8278(18)30683-4. 2018
PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS
Garcia, EG; (...); Ivorra, JAR
Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019
Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.
García-Robles A; (...); Aguar-Carrascosa M
Letter. 10.1016/j.anpedi.2020.06.008. 2021
Preparation and administration of insulin infusions in neonatology: A national survey.
Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta
Article. 10.1016/j.anpede.2020.06.015. 2021
Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services
Company Albir MJ, Poveda Andrés JL, Edo Solsona MD
Article. 10.1016/j.farma.2023.06.0131130. 2024
Presentation and Outcomes of Pregnancy in Patients With Autoimmune Hepatitis.
Llovet LP; (...); Londoño MC
Letter. 10.1016/j.cgh.2018.12.030. 2019
Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Hakeem AR; (...); Rela M
Article. 10.1097/TP.0000000000004769. 2023
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.
Awan, Ahmed Arslan Yousuf; (...); Jadoul, Michel
Article. 10.7326/M23-2391. 2023
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline
Gordon, CE; (...); Martin, P
Article. 10.7326/M19-1539. 2019
Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes.
Ampuero J; (...); Molina E
Letter. 10.1136/gutjnl-2021-325700. 2021
Primary biliary cholangitis in Spain. Results of a Delphi study of epidemiology, diagnosis, follow-up and treatment
Pares, A; (...); Gil, A
Article. 10.17235/reed.2018.5665/2018. 2018
Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology
Fernandez, Ainhoa; (...); Salcedo, Magdalena
Meeting Abstract. 2023
Primary Sclerosing Cholangitis: Gender Effects in Valencia's Low-Prevalence Region.
Minguez, Alejandro; (...); Berenguer, Marina
Article. 10.1007/s10620-024-08368-y. 2024
Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review
Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose
Review. 10.7399/fh.11780. 2021
Proceedings of the 25th Annual Congress of the International Liver Transplantation Society.
Chadha R; (...); Bhangui P
Review. 10.1097/TP.0000000000003160. 2020
Proceedings of the 26th Annual Virtual Congress of the International Liver Transplantation Society.
Kalisvaart, Marit; (...); Kirchner, Varvara
Article. 10.1097/TP.0000000000004183. 2022
Proceedings of the 27th Annual Congress of the International Liver Transplantation Society.
Campos-Varela, Isabel; (...); De Martin, Eleonora
Article. 10.1097/TP.0000000000004637. 2023
Proceedings of the 28th annual congress of the international liver transplantation society.
Shaji Mathew, Johns; (...); Chadha, Ryan
Article. 10.1097/LVT.0000000000000330. 2024
Proceedings of the 29th Annual Congress of the International Liver Transplantation Society.
Patel, Madhukar S; (...); Rammohan, Ashwin
Article. 10.1097/LVT.0000000000000593. 2025
Profile of plasma microRNAs as a potential biomarker of Wilson's disease.
Sanchez-Monteagudo, Ana; (...); Espinos, Carmen
Article. 10.1007/s00535-024-02135-6. 2024
Prognosis of severe HBV reactivation in Western countries: role of the MELD score
Poli, E; (...); Coilly, A
Meeting Abstract. 2021
Prognostic Value of Pre-transplantation Serum Alpha-Fetoprotein Levels in Hepatocellular Carcinoma Recurrence
Montalva EM; (...); Lopez-Andujar R
Article. 10.1016/j.transproceed.2016.07.033. 2016
Prognosticating hepatocellular carcinoma before and after liver transplantation with HepatoPredict
Silva, Silvia Gomes; (...); Cardoso, Joana
Meeting Abstract. 2024
Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler
Megias-Vericat, JE; (...); Poveda, JL
Letter. 10.1097/DSS.0000000000001046. 2017
Protocol for an International Living Donor Liver Transplant Registry ! LDLTregistry.org
Turner, B.; (...); Salinas, C. Hidalgo
Meeting Abstract. 2023
Pushing the donor limits: Deceased donor liver transplantation using organs from octogenarian donors
Díaz Jaime F, Berenguer, M
Article. 10.1002/lt.24841. 2017
Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker
Perez-Alenda, S; (...); Querol, F
Letter. 10.1111/hae.13388. 2018
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study
Buti, M; (...); Esteban, R
Article. 10.1371/journal.pone.0184550. 2017
Re: Tacrolimus Trough Concentrations after Liver Transplantation: .
Di Maira T; (...); Berenguer M
Letter. 10.1097/TP.0000000000003087. 2020
Real-World Effectiveness and Safety of Oral Combination Antiviral Therapy for Hepatitis C Virus Genotype 4 Infection
Crespo, J; (...); Spanish Group for the Study of the Use of Direct-acting Drugs Hepatitis C Collab
Article. 10.1016/j.cgh.2017.02.020. 2017
Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.
Manuel Sousa J; (...); Manzanares A
Article. 10.1371/journal.pone.0225061. 2019
Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients
Aguiar, D; (...); Herrero, JI
Article. 10.12659/AOT.902523. 2017
Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction.
Crespo, Javier; (...); Calleja, Jose Luis
Practice Guideline. 10.1016/j.gastrohep.2022.09.009. 2023
Recommendations of everolimus use in liver transplant
Rubin Suarez, Angel; (...); Prieto Castillo, Martin
Review. 10.1016/j.gastrohep.2017.05.008. 2017
Recompensation following an episode of alcohol-associated hepatitis mostly occurs in the first year of follow-up and is related to Child-Pugh score, levels of GGT and platelets, and alcohol abstinence
Gratacos, Jordi; (...); Pose, Elisa
Meeting Abstract. 2023
Recurrence of Hepatocellular Carcinoma after Liver Transplantation: Clinical Patterns and Hierarchy of Salvage Treatments
Giuliani, Tommaso; (...); Lopez-Andujar, Rafael
Article. 10.1159/000539460. 2024
Recurrent alcohol-associated hepatitis is common and is associated with increased mortality.
Gratacos-Gines, Jordi; (...); Pose, Elisa
Article. 10.1097/HEP.0000000000000825. 2024
Reduction in alert fatigue in an assisted electronic prescribing system, through the Lean Six Sigma methodology.
Cuéllar Monreal MJ; (...); Poveda Andrés JL
Article. 10.7399/fh.2017.41.1.10434. 2017
Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity
Germain, J.; (...); Conde, A.
Meeting Abstract. 2023
Remnant vital tissue following locoregional therapy for hepatocellular carcinoma: another player in the game
Editorial Material. 10.1111/tri.13274. 2018
Reproductive and pregnancy control in Wilson disease patients in Spain.
Romero-Gutiérrez M; (...); Mariño Z
Article. 10.1097/MEG.0000000000002831. 2024
Reversion of disease manifestations after HCV eradication
van der Meer AJ, Berenguer M
Review. 10.1016/j.jhep.2016.07.039. 2016
Rising indication of non-alcoholic steatohepatitis as transplant indication in historically low risk areas
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2022
Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies
Lucena, Ana; (...); Ampuero, Javier
Meeting Abstract. 2023
Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial
Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos
Meeting Abstract. 2023
Safety and Efficacy of Interferon-free Antiviral Treatment in Patients with MELD over 20
Vinaixa, C; (...); Berenguer, M
Meeting Abstract. 2017
Safety and efficacy of ombitasvir/paritaprevir/ritonavir +/- dasabuvir and +/- ribavirin in adult renal or liver transplant recipients with HCV infection (CORAL-I: cohorts 3-6)
Agarwal, K; (...); Forns, X
Meeting Abstract. 10.1016/S0168-8278(17)31461-7. 2017
Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.
Article. 10.1111/ajt.14580. 2018
SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.
Pérez-Encinas M; (...); Calleja-Hernández MÁ
Article. 10.7399/fh.11565. 2020
Selective Indication of T-Tube in Liver Transplantation: Prospective Validation of the Results of a Randomized Controlled Trial
Lopez-Andujar, R; (...); Montalva, EM
Article. 10.1016/j.transproceed.2018.03.133. 2019
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.
Mehta, Gautam; (...); Jalan, Rajiv
Article. 10.1097/HC9.0000000000000273. 2023
Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice
Aguas Peris M; (...); Nos, P
Article. 10.1097/MIB.0000000000001182. 2017
Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice
Meeting Abstract. 2017
Shorter hepatitis B immunoglobulin administration is not associated to hepatitis B virus recurrence when receiving combined prophylaxis after liver transplantation
Lens, S; (...); Forns, X
Article. 10.1111/liv.13858. 2018
Should organs from hepatitis C-positive donors be used in hepatitis C-negative recipients for liver transplantation?
Selzner, N, Berenguer, M
Article. 10.1002/lt.25072. 2018
Should we seek complete liver tests normalization in primary biliary cholangitis? Data from ColHai registry
Diaz-Gonzalez, Alvaro; (...); del Registro, Grupo
Meeting Abstract. 2022
Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH
Ampuero, J; (...); Gomez, MR
Article. 10.1016/j.jhep.2020.02.028. 2020
Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study
Berenguer, Marina; (...); GEMHEP
Article. 10.1016/j.gastrohep.2022.10.018. 2023
Significant heterogeneity in the diagnosis and management of Wilson Disease (WD): results from a large Spanish Registry.
Meeting Abstract. 2017
Significant impact of new oral therapies against HCV on the waiting list for liver transplantation in Spain.
Berenguer, M, de la Rosa Rodríguez G, Dominguez-Gil, B
Letter. 10.1016/j.jhep.2018.06.011. 2018
SIMILAR POST-TRANSPLANT OUTCOMES USING DONORS AFTER CARDIAC DEATH WHEN APPLYING STRICT SELECTION CRITERIA
de la Varga, MF; (...); Aguilera, V
Meeting Abstract. 2021
Similar rates of liver transplantation (LT) for acute liver failure (ALF) but changes in patient profiles in a Spanish multicentre cohort
Conde, I.; (...); Aguilera, V.
Meeting Abstract. 2023
Simple score to assess cardiovascular risk post-liver transplantation
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 2021
SIMPLE SCORE TO ASSESS CARDIOVASCULAR RISK POST-LIVER TRANSPLANTATION
Di Maira, Tommaso; (...); Berenguer, Marina
Meeting Abstract. 2022
Sinusoidal Obstruction Syndrome after Liver Transplantation: A Multicenter Observational Study.
Caballero-Marcos A; (...); Salcedo M
Article. 10.1002/lt.26452. 2022
SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization
Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis
Article. 10.1111/jcpt.13703. 2022
Stretching the boundaries for liver transplant in the 21st century
Trapero-Marugan, M, Little, EC, Berenguer, M
Review. 10.1016/S2468-1253(18)30213-9. 2018
Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?
Cabezas, Joaquin; (...); Crespo, Javier
Meeting Abstract. 2023
SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?
Cabezas, Joaquin; (...); Crespo Garcia, Javier
Meeting Abstract. 2023
Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia
Megías-Vericat JE; (...); Montesinos P
Review. 10.3390/pharmaceutics14040878. 2022
Temporal Trends and Outcomes in Liver Transplantation for Recipients with Human Immunodeficiency Virus Infection in Europe and United States.
Campos-Varela I; (...); Terrault NA
Article. 10.1097/TP.0000000000003107. 2019
Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study
Rodriguez, M; (...); TENOSIMP-B Res Grp
Article. 10.3748/wjg.v23.i41.7459. 2017
The 2024 ILTS-ILCA consensus recommendations for liver transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Kodali, Sudha; (...); Sapisochin, Gonzalo
Article. 10.1097/LVT.0000000000000589. 2025
The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity
Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar
Article. 10.1007/s00431-022-04628-z. 2022
The combination of HEPAmet fibrosis score and transient elastography shows a high diagnostic accuracy in predicting advanced fibrosis in NAFLD
Ampuero, J; (...); Gomez, MR
Meeting Abstract. 10.1016/S0618-8278(19)30234-8. 2019
The concentration of HDV-RNA correlates with the probability of developing clinical events in patients with chronic hepatitis D
Palom, Adriana; (...); Buti, Maria
Meeting Abstract. 2024
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.
Gil-Nagel A; (...); Gil A
Article. 10.1016/j.yebeh.2022.108711. 2022
The effectiveness of daclatasvir based therapy in European patients with chronic hepatitis C and advanced liver disease
Young, J; (...); Calleja, JL
Article. 10.1186/s12879-016-2106-x. 2017
The effects of metabolic status on non-alcoholic fatty liver disease-related outcomes, beyond the presence of obesity
Ampuero, J; (...); HEPAmet Registry
Article. 10.1111/apt.15015. 2018
The Era of the New Centurion: Long Term Outcomes of the Octogenarian Liver
Diaz, FC; (...); Berenguer, M
Meeting Abstract. 2017
The first fifteen days of calcineurin inhibitors exposure do not predict post-transplant malignant outcomes
Di Maira, T; (...); Berenguer, M
Meeting Abstract. 2018
The global prospective observational study to evaluate the role of 'liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE)': study design, demographics and overall outcome
Gustot, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2024
The ILTS Consensus Conference on NAFLD/NASH and Liver Transplantation: Setting the Stage
Burra, P, Berenguer, M, Pomfret, E
Article. 10.1097/TP.0000000000002507. 2019
The ILTS-SETH Consensus Conference on Extrahepatic Cancer and Liver Transplantation: Paving the Way.
Colmenero J, Berenguer M, Watt KD
Article. 10.1097/TP.0000000000003994. 2022
The impact of COVID-19 on liver transplant (LT) centers across the world during the first wave: a Multisociety Survey (EASL-ESOT/ELITA-ILTS)
Russo, FP; (...); Polak, W
Meeting Abstract. 2021
THE IMPACT OF DIRECT ACTING ANTIVIRALS ON HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC RETROSPECTIVE STUDY
Gorgen, A; (...); Sapisochin, G
Meeting Abstract. 2019
The Impact of Direct-acting Antivirals on Overall Mortality and Tumoral Recurrence in Patients With Hepatocellular Carcinoma Listed for Liver Transplantation: An International Multicenter Study
Gorgen, A; (...); Sapisochin, G
Article. 10.1097/TP.0000000000003115. 2020
The interaction between metabolic syndrome and alcohol consumption after an episode of alcohol-associated hepatitis is associated with increased mortality: results from de spanish registry of alcohol-associated liver disease (REHALC)
Gratacos-Gines, Jordi; (...); Pose, Elisa
Meeting Abstract. 2024
The metabolic dysfunction-associated fatty liver disease definition, regardless of its clinical subclassification, identifies patients at high risk for liver disease progression
Del Barrio Azaceta, Maria; (...); Crespo, Javier
Meeting Abstract. 2022
The New Era of Hepatitis C Therapy in Liver Transplant Recipients
Little, EC, Berenguer, M
Article. 10.1016/j.cld.2016.12.012. 2017
THE PRESENCE OF METABOLIC SYNDROME BEFORE TRANSPLANTATION INCREASE THE RISK OF CARDIOVASCULAR EVENTS FOLLOWING LIVER TRANSPLANTATION
Herreras, J; (...); Aguilera, V
Meeting Abstract. 2021
The Reality of Inadequate Patient Care and the Need for a Global Action Framework in Organ Donation and Transplantation.
Domínguez-Gil B; (...); Delmonico FL
Article. 10.1097/TP.0000000000004186. 2022
The road map toward an hepatitis C virus-free transplant population.
Berenguer, M; (...); Samuel, D
Article. 10.1111/ajt.14976. 2018
The role of early extubation on short-term outcomes after liver transplantation - A systematic review, meta-analysis and expert recommendations
Tinguely, Pascale; (...); ERAS4OLT Org Working Grp
Review. 10.1111/ctr.14642. 2022
The role of HBIG in real life for patients undergoing liver transplantation due to HDV-related cirrhosis
Rodriguez-Tajes, Sergio; (...); Forns, Xavier
Article. 10.1111/liv.15777. 2024
The role of prehabilitation on short-term outcomes after liver transplantation - A review of the literature and expert panel recommendations.
Vinaixa C; (...); Samuel D
Article. 10.1111/ctr.14686. 2022
The role of preoperative optimization of the nutritional status on the improvement of short-term outcomes after liver transplantation? A review of the literature and expert panel recommendations
Victor, David W.; (...); ERAS4OLT Org Working Grp
Article. 10.1111/ctr.14647. 2022
The use of prophylactic strategies using hepatitis B immunoglobulin for hepatitis B recurrence after liver transplantation in routine clinical practice in Spain. Preliminary results of the 1st round of a delphi panel
Prieto, M; (...); Casado, MA
Meeting Abstract. 10.1016/S0168-8278(17)30671-2. 2017
The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Badia, Xavier; (...); Valles, Joan-Antoni
Article. 10.1186/s13023-024-03324-5. 2024
The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus
Torrent-Farnell, J; (...); Lizan, L
Article. 10.1016/j.healthpol.2018.03.002. 2018
Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.
Marques MR; (...); Mangas-Sanjuan V
Article. 10.1111/apa.14944. 2020
Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy
Del Rio-Bermudez, C; (...); Poveda, JL
Editorial Material. 10.1186/s40545-020-00276-6. 2020
Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.
Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis
Article. 10.1136/ejhpharm-2024-004184. 2024
Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry
Berenguer, Marina; (...); Marino, Zoe
Meeting Abstract. 2024
Transplant Oncology in Primary and Metastatic Liver Tumor: Principles, Evidence and Opportunities.
Sapisochin G; (...); Mazzaferro V
Article. 10.1097/SLA.0000000000004071. 2020
Transplantation: A Priority in the Healthcare Agenda.
Muller E; (...); Potena L
Article. 10.1097/TP.0000000000005182. 2025
Treatment of Hepatitis C Virus Infection in Patients With Cirrhosis and Predictive Value of Model for End-Stage Liver Disease: Analysis of Data From the Hepa-C Registry
Fernández Carrillo C; (...); Calleja, JL
Article. 10.1002/hep.29097. 2017
Trends in liver transplantation for acute liver failure. A Spanish multicenter study
Conde, Isabel; (...); Berenguer, Marina
Meeting Abstract. 2022
Trends in liver transplantation for acute liver failure: a Spanish multicenter study
Conde, I.; (...); Berenguer, M.
Meeting Abstract. 2022
Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?
Bejar, S; (...); Mateu, PN
Meeting Abstract. 2020
Universal access to direct-acting antivirals treatment is not not enough to prevent late stage presentation of hepatitis C infection
Cabezas, J; (...); Crespo, J
Meeting Abstract. 10.1016/S0618-8278(19)30970-3. 2019
Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy
Garcia, SV; (...); Andres, JLP
Article. 10.1016/j.yrtph.2018.10.002. 2018
USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
Dominguez Hernandez, L.; (...); Gomez Segui, I
Meeting Abstract. 2019
Use of HBsAg-positive donors in liver transplantation: an ILTS-EASLAASLD multisociety survey
Vinaixa, C.; (...); Terrault, N.
Meeting Abstract. 2024
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.
Vinaixa, Carmen; (...); Berenguer, Marina
Article. 10.1097/LVT.0000000000000432. 2024
Usefulness of the biomarker CA125 in the diagnosis of acute cellular rejection in allogeneic heart transplantation
Lopez-Vilella, RLV; (...); Bonet, LABA
Meeting Abstract. 2019
Validation of MELD3.0 in 2 centers from different continents.
Tejedor M; (...); Berenguer M
Article. 10.1097/HC9.0000000000000504. 2024
Validation of MELD3.0 in two centres from different continents
Tejedor Bravo, Marta; (...); Berenguer, Marina
Meeting Abstract. 2023
Validation of MELD3.0 in two centres from different continents
Tejedor, M.; (...); Berenguer, M.
Meeting Abstract. 2023
Validation of the gender-equity model for liver allocation (GEMA) in a nationwide cohort of liver transplant candidates in Spain
Rodriguez-Peralvarez, Manuel; (...); Gastaca, Mikel
Meeting Abstract. 2024
Validation of the liver frailty index as an adverse outcome predictor in the spanish liver transplant setting. Results from a spanish multicentre prospective cohort study.
Puchades, L.; (...); Berenguer, M.
Meeting Abstract. 2023
VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA
Poveda, J. L.; (...); Lizan, L.
Meeting Abstract. 2023
Variation in global living donor liver transplant surgical technique - early data from the International Living Donor Liver Transplant Registry (LDLTregistry.org)
Kantsedikas, I.; (...); Rela, M.
Meeting Abstract. 2024
Variation in global living donor liver transplant surgical technique: Early data from the International Living Donor Liver Transplant Registry
Kantsedikas, Ilya; (...); Rela, Mohamed
Meeting Abstract. 10.1097/01.tp.0001066152.18661.c6. 2024
Very early immunosuppression predicts the first-year renal function post liver transplantation
Di Maira, T.; (...); Berenguer, M.
Meeting Abstract. 2019
Very low access to early liver transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications
Garcia Garcia, S.; (...); Aguilera, V.
Meeting Abstract. 2023
VI consensus document by the Spanish Liver Transplantation Society
Pardo, F; (...); Briceno, J
Article. 10.1016/j.ciresp.2017.12.013. 2018
VI consensus document by the Spanish Liver Transplantation Society
Pardo, F; (...); Briceno, J
Article. 10.1016/j.gastrohep.2018.05.012. 2018
Waiting time dictates impact of frailty: A Spanish multicenter prospective study.
Puchades, Lorena; (...); Berenguer, Marina
Article. 10.1016/j.jhepr.2023.100840. 2023
What is the optimal management of thromboprophylaxis after liver transplantation regarding prevention of bleeding, hepatic artery, or portal vein thrombosis? A systematic review of the literature and expert panel recommendations
Kirchner, Varvara A.; (...); ERAS4OLT Org Working Grp
Review. 2022
Wide variations in liver transplantation (LT) policies across Europe for patients with acute-on-chronic liver failure (ACLF) despite excellent post-LT survival: Results of a CLIF/ELITA collaborative study
Belli, Luca Saverio; (...); Arroyo, Vicente
Meeting Abstract. 2020
Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease
Sánchez-Monteagudo A; (...); Espinós C
Review. 10.3390/biomedicines9091100. 2021
Women are also disadvantaged in accessing transplant outside the United States: analysis of the spanish liver transplantation registry
Tejedor, Marta; (...); Berenguer, Marina
Meeting Abstract. 2024
Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry.
Tejedor, Marta; (...); Berenguer, Marina
Article. 10.3389/ti.2024.12732. 2024
Worldwide variations in COVID-19 vaccination policies and practices in liver transplant settings: results of a multi-society global survey.
Di Maira, Tommaso; (...); Berenguer, Marina
Article. 10.3389/frtra.2023.1332616. 2023
El Impacto De La Inmunosupresión Precoz En Las Complicaciones No Asociadas Al Injerto Hepático
Autor/es: Tommaso Di Maira
Tesis Doctoral
Director/es: MARINA BERENGUER HAYM